The UK’s National Institute for Health and Care Excellence (NICE) has clarified its guidelines on the process of appealing against its guidance for technology appraisals and highly specialised technologies, the decisions of which are crucial to the life sciences industry. Maria Isabel Manley and Victoria Kerr explain the changes.
About Maria Isabel Manley
Entries by Maria Isabel Manley
On March 16, 2023 the Court of Justice of the European Union (CJEU) rendered an important judgment for the pharmaceutical industry as it brings some clarification on the test to […]
The original agreement for the UK’s withdrawal from the EU affected the availability of medicines in Northern Ireland and created issues for importers of medicinal products. The new ‘Windsor Framework’ is better for the industry, as Marie Manley and Bronwyn Tonelli explain.